Published in Exp Ther Med on February 08, 2016
Renal-cell carcinoma. N Engl J Med (2005) 10.17
Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst (1997) 5.07
Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol (2000) 4.98
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am (2003) 3.44
Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol (1999) 2.91
Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol (2002) 2.91
Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J Cancer Prev (2013) 1.58
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene (2007) 1.57
Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl (1995) 1.52
The role of microRNAs in metastasis and epithelial-mesenchymal transition. Cell Mol Life Sci (2009) 1.48
Tea in chemoprevention of cancer. Int J Oncol (1996) 1.47
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci (2008) 1.40
Prognostic factors in renal cell carcinoma. World J Urol (2010) 1.34
Clinical targets for anti-metastasis therapy. Adv Cancer Res (2000) 1.30
(-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett (2008) 1.14
Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. Prostate Cancer Prostatic Dis (2004) 1.07
EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem (2011) 1.05
Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma. J Transl Med (2012) 1.03
Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines. Oncol Rep (2010) 1.01
Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J Agric Food Chem (2010) 1.00
Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells. Toxicol Lett (2014) 0.99
EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Anticancer Res (2004) 0.98
EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G. Cancer Lett (2009) 0.94
Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Anticancer Drugs (2010) 0.91
Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg (2003) 0.89
EGCG inhibits the invasion of highly invasive CL1-5 lung cancer cells through suppressing MMP-2 expression via JNK signaling and induces G2/M arrest. J Agric Food Chem (2011) 0.88
Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo. Nutr Res Pract (2012) 0.87
New treatments for metastatic kidney cancer. Can J Urol (2005) 0.86
Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis. Biosci Biotechnol Biochem (2013) 0.83
EGCG decreases the expression of HIF-1α and VEGF and cell growth in MCF-7 breast cancer cells. J BUON (2014) 0.83
The complex roles of microRNAs in the metastasis of renal cell carcinoma. J Nanosci Nanotechnol (2013) 0.82
Gefitinib decreases the synthesis of matrix metalloproteinase and the adhesion to extracellular matrix proteins of colon cancer cells. Anticancer Res (2006) 0.80
Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines. Int J Cancer (2004) 0.80
Decreased expression of Dkk1 and Dkk3 in human clear cell renal cell carcinoma. Mol Med Rep (2014) 0.87
Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA‑21. Mol Med Rep (2014) 0.86
Nrdp1-mediated degradation of BRUCE decreases cell viability and induces apoptosis in human 786-O renal cell carcinoma cells. Exp Ther Med (2016) 0.75
Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae. Exp Ther Med (2017) 0.75